OPEN END TURBO LONG - RECORDATI INDUSTRIA CHIMICA E FARMA | Market Closed - Börse Stuttgart 14:48:50 2024-05-24 EDT | ||
| 0.5 EUR | -5.66% |
|
| Current month | -21.88% | ||
| 1 month | -23.08% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
| Date | Price | Change |
|---|---|---|
| 24-05-24 | 0.5 | -5.66% |
| 24-05-23 | 0.53 | -5.36% |
| 24-05-22 | 0.56 | -15.15% |
| 24-05-21 | 0.66 | -4.35% |
| 24-05-20 | 0.69 | -6.76% |
Delayed Quote Börse Stuttgart
Last update May 24, 2024 at 02:48 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | RECORDATI |
| Issuer | Morgan Stanley |
| WKN | MB741L |
| ISIN | DE000MB741L0 |
| Date issued | 2023-06-07 |
| Strike | 43.33 € |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.25 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.01 € |
|---|---|
| Lowest since issue | 0.101 € |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
48.34
EUR
Average target price
52.24
EUR
Spread / Average Target
+8.07%
- Stock Market
- Certificates
- Certificat
